CD8+Foxp3+ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor response
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference24 articles.
1. Cutting edge: tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells;Shafer-Weaver;J Immunol,2009
2. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer;Kiniwa;Clin Cancer Res,2007
3. TcR transgenic CD8+ T cells activated in the presence of TGFβ express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection;Kapp;Int. Immunol,2006
4. Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3;Chen;J Exp Med,2003
5. HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice;Reilly;Cancer Res,2000
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program;The American Journal of Pathology;2024-01
2. Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study;Journal for ImmunoTherapy of Cancer;2022-07
3. PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer;JCO Precision Oncology;2022-05
4. High inter‐follicular spatial co‐localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma;Hematological Oncology;2022-04-28
5. TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity;Cancer Letters;2022-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3